In early dementia, SSRIs enhance cognition and major depression.

Published Date: 24 Jun 2023

In patients with major depressive disorder and early-stage dementia, the antidepressant vortioxetine significantly improves depressive symptoms and cognition, according to an open label study.

Read Full News

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Not surprisingly, trust in government health agencies for cancer info has dipped

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

News, features, and commentary about cancer-related issues

Observational study shows greater microplastic burden in patients with lung malignancy

Health news and commentary gathered by MedPage Today staff

News All Time

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Recommended News For You

New Gene Therapy Nears EU Nod for Bladder Cancer

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

In early dementia, SSRIs enhance cognition and major depression.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

Shorter but More Intense RT: A Better Option for HNSCC?

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Recommended Articles For You

Introduction to Immune Thrombocytopenic Purpura 

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology 

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL 

Essential Perspectives in Hematology and Patient Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

2.

Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?

3.

Clinical trial sees dramatic results using radiation to treat breast cancer

4.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

5.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

1.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

2.

Surgical Innovation Using Hematopoietic Reserve Preservation During Major Surgery

3.

Understanding Fibrosarcoma: What You Need to Know 

4.

Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life

5.

The Growing Crisis of Aplastic Anemia: A Call for Action

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Expert Perspectives on Hematology

3.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

Managing Common Side Effects During Cancer Treatment

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot